JP2007525501A5 - - Google Patents

Download PDF

Info

Publication number
JP2007525501A5
JP2007525501A5 JP2007500725A JP2007500725A JP2007525501A5 JP 2007525501 A5 JP2007525501 A5 JP 2007525501A5 JP 2007500725 A JP2007500725 A JP 2007500725A JP 2007500725 A JP2007500725 A JP 2007500725A JP 2007525501 A5 JP2007525501 A5 JP 2007525501A5
Authority
JP
Japan
Prior art keywords
chromatography
antibody
resin
multimodal
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007500725A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007525501A (ja
JP4848356B2 (ja
Filing date
Publication date
Priority claimed from SE0400501A external-priority patent/SE0400501D0/xx
Priority claimed from SE0402558A external-priority patent/SE0402558D0/xx
Application filed filed Critical
Priority claimed from PCT/SE2005/000293 external-priority patent/WO2005082483A1/en
Publication of JP2007525501A publication Critical patent/JP2007525501A/ja
Publication of JP2007525501A5 publication Critical patent/JP2007525501A5/ja
Application granted granted Critical
Publication of JP4848356B2 publication Critical patent/JP4848356B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007500725A 2004-02-27 2005-02-25 抗体精製法 Expired - Lifetime JP4848356B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0400501-3 2004-02-27
SE0400501A SE0400501D0 (sv) 2004-02-27 2004-02-27 Antibody purification
SE0402558A SE0402558D0 (sv) 2004-10-21 2004-10-21 A process for the purification of antibodies
SE0402558-1 2004-10-21
PCT/SE2005/000293 WO2005082483A1 (en) 2004-02-27 2005-02-25 A process for the purification of antibodies

Publications (3)

Publication Number Publication Date
JP2007525501A JP2007525501A (ja) 2007-09-06
JP2007525501A5 true JP2007525501A5 (https=) 2008-04-10
JP4848356B2 JP4848356B2 (ja) 2011-12-28

Family

ID=34914633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007500725A Expired - Lifetime JP4848356B2 (ja) 2004-02-27 2005-02-25 抗体精製法

Country Status (9)

Country Link
US (1) US7750129B2 (https=)
EP (1) EP1718386A1 (https=)
JP (1) JP4848356B2 (https=)
KR (1) KR101150050B1 (https=)
AU (1) AU2005216847B2 (https=)
CA (1) CA2552639C (https=)
IL (1) IL176745A (https=)
NZ (1) NZ548126A (https=)
WO (1) WO2005082483A1 (https=)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101243601B1 (ko) 2004-10-21 2013-03-20 지이 헬스케어 바이오-사이언시스 에이비 크로마토그래피 리간드
CN100395001C (zh) * 2006-01-26 2008-06-18 合肥工业大学 一种半固定配位色谱分离方法
WO2007108955A1 (en) * 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
KR20140071452A (ko) * 2006-04-05 2014-06-11 애브비 바이오테크놀로지 리미티드 항체 정제
CA2655873C (en) 2006-07-14 2017-10-17 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
EP2099957A1 (en) * 2007-01-10 2009-09-16 GE Healthcare Bio-Sciences AB Multi-modal ion exchange chromotography resins
JP5888481B2 (ja) 2007-03-28 2016-03-22 ディーピーエックス ホールディングス ビー．ブイ． 膨張床カラムおよび使い捨て可能なクロマトグラフィー
EP2027875A1 (en) * 2007-08-23 2009-02-25 Octapharma AG A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC)
CA2703086C (en) * 2007-10-26 2014-11-25 Asahi Kasei Chemicals Corporation Method for purifying protein
ES2735173T3 (es) * 2007-12-31 2019-12-16 Baxalta GmbH Furina recombinante sustancialmente libre de proteína animal y métodos para producir la misma
US8188242B2 (en) * 2008-04-08 2012-05-29 Bio-Rad Laboratories, Inc. Chromatography purification of antibodies
KR20160104740A (ko) * 2008-06-24 2016-09-05 옥타파마 아게 응고 인자 ｖｉｉｉ을 정제하는 방법
US20110166332A1 (en) * 2008-09-12 2011-07-07 Ge Healthcare Bio-Sciences Ab Enhanced antibody aggregate removal with capto adhere in the presence of protein-excluded zwitterions
KR20100070994A (ko) 2008-12-18 2010-06-28 토소가부시키가이샤 액체 크로마토그래피용 충전 재료 및 해당 충전 재료에 의한 생체고분자의 분리·정제 방법
JPWO2010071208A1 (ja) 2008-12-19 2012-05-31 武田薬品工業株式会社 抗体の精製方法
JPWO2011001963A1 (ja) 2009-07-03 2012-12-13 旭化成ケミカルズ株式会社 多孔質基材に固定されたグラフト鎖に結合しているアミノ基及びアルキル基を有する多孔膜を用いた抗体の精製方法
EP2459308A1 (en) 2009-07-28 2012-06-06 instrAction GmbH Specific sorbent for binding proteins and peptides, and separation method using the same
US20120208986A1 (en) * 2009-10-20 2012-08-16 Wenger Marc D Use of mixed mode chromatography for the capture and purification of basic antibody products
DK2552948T3 (en) 2010-03-30 2016-10-17 Octapharma Ag A process for the purification of the protein growth factor G-CSF
EP2553095B1 (en) 2010-03-30 2016-10-12 Octapharma AG A process for purifying vitamin K dependent proteins such as coagulation factor IX
EP2585887B1 (en) 2010-06-23 2019-01-09 GE Healthcare Bio-Sciences AB Method of preparing liquid mixtures
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US20140187749A1 (en) 2011-06-16 2014-07-03 Dsm Ip Assets B.V. Single unit chromatography antibody purification
SG10201605397PA (en) 2011-07-01 2016-08-30 Hoffmann La Roche Method For Separation Of Monomeric Polypeptides From Aggregated Polypeptides
US8802448B2 (en) 2011-07-27 2014-08-12 Pall Corporation Mixed mode ligands
ES2690213T3 (es) 2011-12-15 2018-11-19 Prestige Biopharma Pte. Ltd. Un método de purificación de anticuerpos
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
HK1211981A1 (en) 2012-09-02 2016-06-03 Abbvie Inc. Methods to control protein heterogeneity
SG11201501597VA (en) * 2012-09-03 2015-04-29 Kaneka Corp Mix-mode antibody affinity separation matrix and purification method using same, and target molecule
EA031324B1 (ru) 2012-09-11 2018-12-28 Кохерус Байосайенсис, Инк. Правильно свернутый этанерцепт с высокой чистотой и высоким уровнем выхода
EP2919902B1 (en) 2012-11-13 2020-01-01 GE Healthcare BioProcess R&D AB Multimodal anion exchange matrices
CN103217489B (zh) * 2013-01-15 2016-03-09 珠海市丽珠单抗生物技术有限公司 一种测定蛋白纯化工艺过程中样品的糖基化和末端修饰情况的方法
JP2016513245A (ja) * 2013-02-06 2016-05-12 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ タンパク質製剤の凝集体含有量を減少させる混合多官能金属親和性表面
ES2912930T3 (es) 2013-02-26 2022-05-30 Merck Millipore Ltd Membranas de cromatografía en modo mixto
SG10201709131UA (en) 2013-03-08 2017-12-28 Genzyme Corp Continuous purification of therapeutic proteins
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
JPWO2015041218A1 (ja) 2013-09-17 2017-03-02 株式会社カネカ 新規抗体精製方法及びそれから得られる抗体（ＮｏｖｅｌＡｎｔｉｂｏｄｙＰｕｒｉｆｉｃａｔｉｏｎＭｅｔｈｏｄａｎｄＡｎｔｉｂｏｄｙｏｂｔａｉｎｅｄｔｈｅｒｅｆｒｏｍ）、並びに陽イオン交換基を用いた新規抗体精製法及びそれから得られる抗体（ＮｏｖｅｌＡｎｔｉｂｏｄｙＰｕｒｉｆｉｃａｔｉｏｎｍｅｔｈｏｄｕｓｉｎｇＣａｔｉｏｎＥｘｃｈａｎｇｅｒａｎｄＡｎｔｉｂｏｄｙｏｂｔａｉｎｅｄｔｈｅｒｅｆｒｏｍ）
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20160251441A1 (en) * 2013-10-25 2016-09-01 Medimmune, Llc Antibody purification
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
ES2784749T3 (es) 2014-03-10 2020-09-30 Richter Gedeon Nyrt Purificación de inmunoglobulina con el uso de etapas de limpieza previa
WO2015137860A1 (en) * 2014-03-14 2015-09-17 Ge Healthcare Bio-Sciences Ab Separation matrices for purification of biological particles
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
DE102016004432A1 (de) * 2016-04-12 2017-10-12 Sartorius Stedim Biotech Gmbh Multimodales Adsorptionsmedium mit multimodalen Liganden, Verfahren zu dessen Herstellung und dessen Verwendung
CN109563124A (zh) * 2016-06-17 2019-04-02 豪夫迈·罗氏有限公司 多特异性抗体的纯化
KR102369014B1 (ko) 2016-08-16 2022-03-02 리제너론 파아마슈티컬스, 인크. 혼합물로부터 개별 항체들을 정량하는 방법
EA201990986A1 (ru) 2016-10-25 2019-09-30 Ридженерон Фармасьютикалз, Инк. Способы и системы анализа хроматографических данных
WO2019060062A1 (en) 2017-09-19 2019-03-28 Regeneron Pharmaceuticals Inc. METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREFROM
EP3746538A1 (en) * 2018-01-30 2020-12-09 Exothera SA Protein purification process
TWI853823B (zh) 2018-07-02 2024-09-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
HK40046210A (en) * 2018-08-31 2021-10-29 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
EA202192422A1 (ru) 2019-03-05 2021-12-09 Ридженерон Фармасьютикалз, Инк. Человеческий сывороточный альбумин в составах
CN114213525B (zh) * 2021-12-30 2024-05-28 科兴生物制药股份有限公司 一种生长激素的纯化方法
CN119034260B (zh) * 2024-09-10 2025-09-05 中国地质大学（武汉） 一种利用强阳离子树脂分离三价锑和五价锑的系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU581927A1 (ru) * 1975-12-31 1977-11-30 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Устройство дл получени стерильных растворов дочерних радиоактивных изотопов медицинского назначени
SE462046C (sv) 1982-08-23 1998-04-27 Pharmacia Biotech Ab Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma
US5151350A (en) 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
AU5957794A (en) * 1992-12-21 1994-07-19 Uab Research Foundation, The Compositions and method for the inhibition of phagocytes
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
GB9519197D0 (en) * 1995-09-20 1995-11-22 Affinity Chromatography Ltd Novel affinity ligands and their use
ATE441476T1 (de) 1996-08-30 2009-09-15 Upfront Chromatography As Isolierung von immunoglobulinen
US6440933B1 (en) * 1997-09-10 2002-08-27 University Of Florida Compounds and method for the prevention and treatment of diabetic retinopathy
SE9904197D0 (sv) 1999-11-22 1999-11-22 Amersham Pharm Biotech Ab A method for anion exchange adsorption on matrices carrying mixed mode ligands
SE0002688D0 (sv) 2000-07-17 2000-07-17 Amersham Pharm Biotech Ab Adsorption method and ligands
CA2431662A1 (en) * 2000-12-31 2002-07-11 Amersham Biosciences Ab A method for the manufacture of compositions containing low concentrations of salts
JP2004517310A (ja) * 2001-01-05 2004-06-10 プロ・ケム インク 精製器具及び方法
WO2002057498A1 (en) * 2001-01-22 2002-07-25 Emergen, Inc. Isotopically enriched nucleic acids and associated methods for the production and purification thereof
US6652853B2 (en) * 2001-03-08 2003-11-25 Ludwig Institute For Cancer Research Method for treating cancer using A33 specific antibodies and chemotherapeutic agents
SE0103084D0 (sv) * 2001-09-14 2001-09-14 Amersham Pharm Biotech Ab Generation of ion exchange media

Similar Documents

Publication Publication Date Title
JP2007525501A5 (https=)
CA2552639A1 (en) A process for the purification of antibodies
Salimi et al. Protein A and protein A/G coupled magnetic SiO2 microspheres for affinity purification of immunoglobulin G
Boi Membrane adsorbers as purification tools for monoclonal antibody purification
Josić et al. Application of membranes and compact, porous units for the separation of biopolymers
Jain et al. Protein purification with polymeric affinity membranes containing functionalized poly (acid) brushes
IL176635A0 (en) Antibody purification
JP2008517906A5 (https=)
Lee et al. Negative chromatography: Progress, applications and future perspectives
JP2010534336A5 (https=)
EP1918372A4 (en) FOR BINDING TO IMMOBILIZABLE LOBULIN G-NUCLEIC ACID AND USE THEREOF
JPS63249052A (ja) 親和クロマトグラフイ用吸着材
Tishchenko et al. Purification of the specific immunoglobulin G1 by immobilized metal ion affinity chromatography using nickel complexes of chelating porous and nonporous polymeric sorbents based on poly (methacrylic esters): effect of polymer structure
Bereli et al. Histidine containing macroporous affinity cryogels for immunoglobulin G purification
SE0400490D0 (sv) Plasmid purification
Gunasena et al. Organic monoliths for hydrophilic interaction electrochromatography/chromatography and immunoaffinity chromatography
JP2008503754A5 (https=)
Chiu et al. Isolation of lysozyme from hen egg albumen using glass fiber-based cation-exchange membranes
Dong et al. Functionalizing microporous membranes for protein purification and protein digestion
Zang et al. Direct site-specific immobilization of protein A via aldehyde-hydrazide conjugation
Ko et al. Simultaneous purification and immobilization of d-hydantoinase on the immobilized metal affinity membrane via coordination bonds
Rajak et al. Purification of monoclonal antibodies, IgG1, from cell culture supernatant by use of metal chelate convective interaction media monolithic columns
Champagne et al. Pseudoaffinity chromatography using a convective interaction Media®-disk monolithic column
Wongchuphan et al. Application of dye-ligands affinity adsorbent in capturing of rabbit immunoglobulin G
Tripathi et al. Integrated approach for β-glucosidase purification from non-clarified crude homogenate using macroporous cryogel matrix